自然化合物和编程死亡:开拓癌症治疗的新前沿
Md Al Amin1, Hasna Bouhenni2, Mehrukh Zehravi3
1Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, 1216, Bangladesh. amin29-825@diu.edu.bd.
Naunyn-Schmiedeberg's archives of pharmacology
|March 26, 2025
概括
天然化合物提供了一种有前途的策略,通过调节编程亡 (编程细胞死亡) 途径来向癌细胞,潜在地克服治疗耐药性并最大限度地减少副作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 编程性亡是一种细胞死亡途径,可以绕过癌症中的亡抵抗.
- 自然产品具有多样化的生物活性和低毒性,这使得它们对癌症治疗具有吸引力.
- 了解编程亡机制对于开发新型抗癌疗法至关重要.
研究的目的:
- 审查自然化合物的潜力,以调节癌症治疗的编程死亡途径.
- 突出自然化合物的相互作用与关键编程亡机制,如ferroptosis和necroptosis.
- 探索癌症中自然化合物诱导的编程细胞死亡背后的分子机制.
主要方法:
- 编程亡途径和自然化合物相互作用的文献综述.
- 分析分子机制,包括脂质过氧化和激酶信号 (RIPK1/RIPK3).
- 在癌症模型中检查自然化合物 (多,类,类) 的临床前数据.
主要成果:
- 自然化合物可以有效地向癌细胞,同时节省健康的组织.
- 特定的天然化合物调节铁亡和亡途径.
- 多,类和类在癌症临床前研究中显示出有前途的结果.
结论:
- 自然化合物是开发针对计划性亡的新型癌症治疗方法的可行来源.
- 将天然产品药理与计划性亡研究相结合,可以克服癌症治疗耐药性.
- 在临床前模型和分子生物学中进行进一步的研究可以提高天然化合物的癌症治疗疗效.
相关概念视频
Necrosis
3.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.8K
Overview of Cell Death
5.9K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
5.9K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
Apoptosis
10.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
10.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


